According to the Wall Street Journal, Johnson & Johnson sought help from other vaccine makers to look into reports of blood clots, but Pfizer and Moderna both declined, only AstraZeneca agreed.
The post J&J Reportedly Sought Help From Rivals After Blood Clot Concerns Emerged appeared first on The Seattle Medium.
